Literature DB >> 14989227

131I/123I-metaiodobenzylguanidine (MIBG) scintigraphy: procedure guidelines for tumour imaging.

Emilio Bombardieri1, Cumali Aktolun, Richard P Baum, Angelika Bishof-Delaloye, John Buscombe, Jean François Chatal, Lorenzo Maffioli, Roy Moncayo, Luc Mortelmans, Sven N Reske.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14989227     DOI： 10.1007/s00259-003-1357-0

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  29 in total

1.  Radiological Protection in Biomedical Research. A report of Committee 3 adopted by the International Commission on Radiological Protection.

Authors: 
Journal:  Ann ICRP       Date:  1991

2.  Specificity of radioiodinated MIBG for neural crest tumors in childhood.

Authors:  A Leung; B Shapiro; R Hattner; E Kim; J de Kraker; N Ghazzar; O Hartmann; C A Hoefnagel; D A Jamadar; R Kloos; P Lizotte; J Lumbroso; V Rufini; B L Shulkin; J C Sisson; A Thein; L Troncone
Journal:  J Nucl Med       Date:  1997-09       Impact factor: 10.057

3.  Radiation dose to patients from radiopharmaceuticals (addendum 2 to ICRP publication 53).

Authors: 
Journal:  Ann ICRP       Date:  1998

4.  Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours.

Authors:  S Adams; R Baum; T Rink; P M Schumm-Dräger; K H Usadel; G Hör
Journal:  Eur J Nucl Med       Date:  1998-01

5.  Staging of neuroblastoma at imaging: report of the radiology diagnostic oncology group.

Authors:  Marilyn J Siegel; Hemant Ishwaran; Barry D Fletcher; James S Meyer; Fredric A Hoffer; Diego Jaramillo; Ramiro J Hernandez; Susan E Roubal; Barry A Siegel; Daryl J Caudry; Barbara J McNeil
Journal:  Radiology       Date:  2002-04       Impact factor: 11.105

Review 6.  Nuclear medicine procedures and neuroblastoma in childhood. Their value in the diagnosis, staging and assessment of response to therapy.

Authors:  A Boubaker; A Bischof Delaloye
Journal:  Q J Nucl Med       Date:  2003-03

7.  Combined diagnostic imaging with 131I-metaiodobenzylguanidine and 111In-pentetreotide in carcinoid tumours.

Authors:  B G Taal; C A Hoefnagel; R A Valdés Olmos; H Boot
Journal:  Eur J Cancer       Date:  1996-10       Impact factor: 9.162

8.  Evaluation of (111)In-pentetreotide, (131)I-MIBG and bone scintigraphy in the detection and clinical management of bone metastases in carcinoid disease.

Authors:  J M Zuetenhorst; C A Hoefnageli; H Boot; R A Valdés Olmos; B G Taal
Journal:  Nucl Med Commun       Date:  2002-08       Impact factor: 1.690

9.  Refining interpretation of MIBG scans in children.

Authors:  F Bonnin; J Lumbroso; F Tenenbaum; O Hartmann; C Parmentier
Journal:  J Nucl Med       Date:  1994-05       Impact factor: 10.057

Review 10.  Functional scintigraphy of the adrenal gland.

Authors:  Domenico Rubello; Chuong Bui; Dario Casara; Milton D Gross; Lorraine M Fig; Brahm Shapiro
Journal:  Eur J Endocrinol       Date:  2002-07       Impact factor: 6.664
View more
  16 in total

1.  Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr 3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine.

Authors:  Alexander Kroiss; Daniel Putzer; Christian Uprimny; Clemens Decristoforo; Michael Gabriel; Wolfram Santner; Christof Kranewitter; Boris Warwitz; Dietmar Waitz; Dorota Kendler; Irene Johanna Virgolini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-01-29       Impact factor: 9.236

2.  Diagnostic cutoff points for ¹²³I-MIBG myocardial scintigraphy in a Caucasian population with Parkinson's disease.

Authors:  Africa Muxí; Pilar Paredes; Ignacio Navales; Francesc Valldeoriola; Carles Gaig; Francisco Lomeña; Andres de la Cerda; Oriol Solà; Beatriz Domenech; Eduardo Tolosa; Francesca Pons
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-03-04       Impact factor: 9.236

3.  Iodine-131MIBG SPECT/CT in neuroendocrine tumours: An institutional experience.

Authors:  Priyanka Verma; Julie Hephzibah; Nylla Shanthly; Regi Oommen
Journal:  Indian J Nucl Med       Date:  2012-10

4.  Iodine-123 metaiodobenzylguanidine scintigraphy for the assessment of cardiac sympathetic innervation and the relationship with cardiac autonomic function in healthy adults using standardized methods.

Authors:  Omar Asghar; Parthiban Arumugam; Ian Armstrong; Simon Ray; Matthias Schmitt; Rayaz A Malik
Journal:  Nucl Med Commun       Date:  2017-01       Impact factor: 1.690

Review 5.  Molecular imaging of neuroendocrine tumors.

Authors:  Jorge A Carrasquillo; Clara C Chen
Journal:  Semin Oncol       Date:  2010-12       Impact factor: 4.929

6.  Sensitivity of surveillance studies for detecting asymptomatic and unsuspected relapse of high-risk neuroblastoma.

Authors:  Brian H Kushner; Kim Kramer; Shakeel Modak; Nai-Kong V Cheung
Journal:  J Clin Oncol       Date:  2009-01-26       Impact factor: 44.544

Review 7.  Imaging in targeted delivery of therapy to cancer.

Authors:  Gairin Dancey; Richard H Begent; Tim Meyer
Journal:  Target Oncol       Date:  2009-10-08       Impact factor: 4.493

Review 8.  Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force.

Authors:  K K Matthay; B Shulkin; R Ladenstein; J Michon; F Giammarile; V Lewington; A D J Pearson; S L Cohn
Journal:  Br J Cancer       Date:  2010-04-27       Impact factor: 7.640

Review 9.  Non-invasive methods for the assessment of brown adipose tissue in humans.

Authors:  Maria Chondronikola; Scott C Beeman; Richard L Wahl
Journal:  J Physiol       Date:  2018-01-15       Impact factor: 5.182

10.  Usefulness of 123I-MIBG scintigraphy in the evaluation of patients with known or suspected primary or metastatic pheochromocytoma or paraganglioma: results from a prospective multicenter trial.

Authors:  Gregory A Wiseman; Karel Pacak; Mary S O'Dorisio; Donald R Neumann; Alan D Waxman; David A Mankoff; Sherif I Heiba; Aldo N Serafini; Sabah S Tumeh; Natalie Khutoryansky; Arnold F Jacobson
Journal:  J Nucl Med       Date:  2009-08-18       Impact factor: 10.057
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.